ResMed Inc. RMD
222.00
0.11
0.05%
as of 25 Sep
- Market cap
- $31.9B
- P/E
- 21.3×
Follow RMD
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
ResMed Inc. (RMD) Debt to equity
ResMed Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.1×. Over the past ten years it has ranged from 0.1× (fiscal 2026) to 0.6× (fiscal 2019) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.1× | (44.97%) |
| FY2025 | 0.1× | (23.08%) |
| FY2024 | 0.1× | (58.63%) |
| FY2023 | 0.3× | 52.22% |
| FY2022 | 0.2× | 2.15% |
| FY2021 | 0.2× | (52.19%) |
| FY2020 | 0.5× | (23.26%) |
| FY2019 | 0.6× | 363.39% |
| FY2018 | 0.1× | (76.17%) |
| FY2017 | 0.6× | 6.77% |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.1× | (2.57%) |
| Mar 2026 | 0.1× | (2.50%) |
| Dec 2025 | 0.1× | (4.34%) |
| Sep 2025 | 0.1× | (39.44%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.1×
High 0.6×
Ten-year median
0.2×
Current reading's percentile
8
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| RMD ResMed Inc. | 0.1× |
| WST West Pharmaceutical Services, Inc. compare | 0.1× |
| ALC Alcon compare | 0.2× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| BDX Becton, Dickinson and Company compare | 0.6× |
| MDLN Medline Inc. compare | 0.7× |
| SOLV Solventum Corporation compare | 1.1× |
| BAX Baxter International Inc. compare | 1.5× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on RMD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement